Literature DB >> 9150904

Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice.

R J Hambly1, J A Double, M J Thompson, M C Bibby.   

Abstract

Human breast cancer cell lines are required as models for use in the understanding of breast carcinoma, and for improving the ability of cell screens to detect appropriate anti-cancer agents. Four human breast cancer cell lines (MT-1, MaTu. MT-3 and MC4000) were established from human tumour xenografts grown in nude mice. All the lines were shown to be of human origin by karyotype analysis, were epithelial in morphology by both light and electron microscopy, were positive for cytokeratin 18, and were free from mycoplasma, bacterial, yeast and fungal contamination. All of the new lines were shown to be ER and PgR negative, while using the same procedures (i.e. radioligand binding and immunohistochemical staining) the positive control cell line MCF-7 was shown to be positive. MaTu had been previously reported as ER and PgR positive in vivo and it may be that this characteristic had been lost due to in vitro selection pressures. The growth rates of all the new breast cancer cell lines were similar and within the limits required for incorporation into a panel for screening anti-cancer drugs by a microtetrazolium based, colorimetric growth inhibition assay. Three of the lines (MT-1. MaTu and MC4000) were also able to grow into macroscopic colonies for use in a non-agar clonogenic assay. In addition, both MT-1 and MaTu formed spheroids and were clonogenic in soft-agar. The new lines demonstrated a wide range of sensitivities to anticancer agents commonly used in the treatment of breast cancer, and together with their corresponding xenografts are providing additional systems for the evaluation of new compounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150904     DOI: 10.1023/a:1005756632293

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  The pitfalls of platform comparison: DNA copy number array technologies assessed.

Authors:  Christina Curtis; Andy G Lynch; Mark J Dunning; Inmaculada Spiteri; John C Marioni; James Hadfield; Suet-Feung Chin; James D Brenton; Simon Tavaré; Carlos Caldas
Journal:  BMC Genomics       Date:  2009-12-08       Impact factor: 3.969

2.  Creation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumor.

Authors:  Shaojin You; Wei Li; Minoru Kobayashi; Yin Xiong; William Hrushesky; Patricia Wood
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jul-Aug       Impact factor: 2.416

3.  Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.

Authors:  William Weidong Du; Burton B Yang; Bing L Yang; Zhaoqun Deng; Ling Fang; Sze Wan Shan; Zina Jeyapalan; Yaou Zhang; Arun Seth; Albert J Yee
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

4.  Molecular cytogenetic analysis of breast cancer cell lines.

Authors:  J M Davidson; K L Gorringe; S F Chin; B Orsetti; C Besret; C Courtay-Cahen; I Roberts; C Theillet; C Caldas; P A Edwards
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

5.  PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes.

Authors:  Anna Git; Inmaculada Spiteri; Cherie Blenkiron; Mark J Dunning; Jessica C M Pole; Suet-Feung Chin; Yanzhong Wang; James Smith; Frederick J Livesey; Carlos Caldas
Journal:  Breast Cancer Res       Date:  2008-06-27       Impact factor: 6.466

6.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.

Authors:  J Tian; Z Y Tang; S L Ye; Y K Liu; Z Y Lin; J Chen; Q Xue
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

7.  Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.

Authors:  Phyllis Fung-Yi Cheung; Chi Wai Yip; Linda Wing-Chi Ng; Kwok Wai Lo; Nathalie Wong; Kwong Wai Choy; Chit Chow; Kui Fat Chan; Tan To Cheung; Ronnie Tung-Ping Poon; Sheung Tat Fan; Siu Tim Cheung
Journal:  Cancer Cell Int       Date:  2014-10-09       Impact factor: 5.722

8.  Characterization of two novel cell lines with distinct heterogeneity derived from a single human bile duct carcinoma.

Authors:  Jinghan Wang; Linfang Li; Keqiang Zhang; Yong Yu; Bin Li; Jiang Li; Zi Yan; Zhenli Hu; Yun Yen; Mengchao Wu; Xiaoqing Jiang; Qijun Qian
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines.

Authors:  Behnam Kamalidehghan; Massoud Houshmand; Fereydoun Kamalidehghan; Narges Jafarzadeh; Shahram Azari; Sharifah Noor Akmal; Rozita Rosli
Journal:  Cancer Cell Int       Date:  2012-10-29       Impact factor: 5.722

10.  Models of breast cancer: is merging human and animal models the future?

Authors:  Jong B Kim; Michael J O'Hare; Robert Stein
Journal:  Breast Cancer Res       Date:  2003-08-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.